Endocrinology and Metabolism Clinics of North America

Papers
(The median citation count of Endocrinology and Metabolism Clinics of North America is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
An Update on the Epidemiology of Type 2 Diabetes149
The Epidemiology of Pituitary Adenomas129
Postmenopausal Osteoporosis91
Evolution of Diabetes Technology44
Lipid and Lipoprotein Metabolism44
Physiology of Calcium Homeostasis40
Benefits and Challenges of Diabetes Technology Use in Older Adults39
Diabetes Insipidus37
Diabetes Technology in the Inpatient Setting for Management of Hyperglycemia36
Sex Differences in Adipose Tissue Function35
Diagnosis of Polycystic Ovary Syndrome35
Pituitary Tumors Centers of Excellence33
Do-It-Yourself Artificial Pancreas System and the OpenAPS Movement32
Aggressive Pituitary Adenomas and Carcinomas28
Pediatric Thyroid Cancer27
Diabetes and Osteoporosis26
Growth Hormone and Obesity25
Screening for Diabetes and Prediabetes25
Prevention of Microvascular Complications of Diabetes25
Diabetes Technology Use in Adults with Type 1 and Type 2 Diabetes24
New and Emerging Technologies in Type 1 Diabetes24
HbA1c22
2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease21
Update on the Genetics of Pituitary Tumors21
The Role of Dopamine Agonists in Pituitary Adenomas20
Management of Hypothalamic Obesity19
The Changing Nature of Mortality and Morbidity in Patients with Diabetes19
Visceral Fat19
Advances in the Imaging of Pituitary Tumors19
Advances in the Medical Treatment of Cushing Disease18
Endoscopic Surgery for Pituitary Tumors17
Role of Glucagon in Automated Insulin Delivery16
Use of Diabetes Technology in Children16
Automated Insulin Delivery in Adults16
Assessment of Cardiovascular Disease Risk16
Inhaled Corticosteroids and Endocrine Effects in Childhood16
Anaplastic Thyroid Cancer15
Psychosocial Aspects of Diabetes Technology Use15
Psychosocial Aspects of Diabetes Technology15
Definition and Classification of Diabetes and Prediabetes and Emerging Data on Phenotypes14
World Health Ozganization 2017 Classification of Pituitary Tumors14
Characterizing Multimorbidity from Type 2 Diabetes14
Nelson’s Syndrome13
Cardiometabolic Risk in Polycystic Ovary Syndrome13
Update on Rare Adverse Events from Osteoporosis Therapy and Bisphosphonate Drug Holidays13
Acromegaly13
Barriers and Solutions for Prescribing Obesity Pharmacotherapy13
Dyslipidemia in Diabetes12
Ethnic Disparities in Diabetes12
Pediatric Type 2 Diabetes: Not a Mini Version of Adult Type 2 Diabetes12
Osteoporosis11
Diabetes Technology and Exercise11
Role of Bone Turnover Markers in Osteoporosis Therapy11
Nonclassic Congenital Adrenal Hyperplasia11
Effects of Overweight and Obesity in Pregnancy on Health of the Offspring11
Regulation of the Hypothalamic-Pituitary-Testicular Axis: Pathophysiology of Hypogonadism11
A Novel Etiology of Hypophysitis11
Genetics of Polycystic Ovary Syndrome11
Updates on Osteoporosis in Men11
Testosterone Replacement Therapy in Hypogonadal Men10
Hereditary Primary Hyperparathyroidism10
Polycystic Ovary Syndrome10
Delayed and Precocious Puberty: Genetic Underpinnings and Treatments10
Common and Rare Complications of Bariatric Surgery9
Diabetes and Osteoporosis9
Hypertriglyceridemia9
Management of Women with Polycystic Ovary Syndrome During Pregnancy9
Prevention of Type 2 Diabetes9
Phthalate Exposure, Adolescent Health, and the Need for Primary Prevention9
Bone Health in Childhood Chronic Disease9
Testosterone, Diabetes Risk, and Diabetes Prevention in Men8
Obesity and Aging8
Epidemiology of Male Hypogonadism8
Overview of Atypical Diabetes8
Strategies for Physical Activity Interventions in the Treatment of Obesity8
Postmenopausal Hyperandrogenism8
Safety of Statins and Nonstatins for Treatment of Dyslipidemia7
Role of Commercial Weight-Loss Programs in Medical Management of Obesity7
Hypercalcemia of Malignancy7
Testosterone Treatment As a Function-Promoting Therapy in Sarcopenia Associated with Aging and Chronic Disease7
Accurate Measurement and Harmonized Reference Ranges for Total and Free Testosterone Levels7
Symptoms of Late-Onset Hypogonadism in Men6
Nonalcoholic Fatty Liver Disease6
Automated Insulin Delivery in Children with Type 1 Diabetes6
Disparities in Thyroid Care6
Integration of Diabetes Technology in Clinical Practice6
Denosumab Discontinuation in Patients Treated for Low Bone Density and Osteoporosis6
Advances in the Bone Health Assessment of Children6
Pathophysiology of Hypercalcemia6
Vitamin D–dependent Hypercalcemia6
Sexual Dysfunctions in Women6
Evaluating the Impact of Acromegaly on Quality of Life6
Fertility Issues in Polycystic Ovarian Disease5
Parathyroid Carcinoma and Ectopic Secretion of Parathyroid hormone5
Tertiary and Postrenal Transplantation Hyperparathyroidism5
Update on Approved Osteoporosis Therapies Including Combination and Sequential Use of Agents5
The Future of Thyroid Nodule Risk Stratification5
The Inherited Hypercholesterolemias5
Glucocorticoid- and Transplantation-Induced Osteoporosis5
Assessment of Skeletal Strength4
Cardiovascular Implications of Metabolic Dysfunction-Associated Fatty Liver Disease4
Role of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism4
Metabolic-Associated Fatty Liver Disease and Sarcopenia4
Treatment of Hypercalcemia of Malignancy4
Rekindling Hope for Remission4
Novel Therapeutics and Treatment Strategies for Medullary Thyroid Cancer4
Quality of Life in Primary Hyperparathyroidism4
Diabetes in Youth4
Endocrine Sequelae in Childhood Cancer Survivors4
Hypercalcemia in Pregnancy4
Root Cause for Metabolic Syndrome and Type 2 Diabetes4
Management of Menopause Symptoms and Quality of Life during the Menopause Transition4
Diagnostic and Treatment Considerations for Thyroid Cancer in Women of Reproductive Age and the Perinatal Period4
Thyroid and Aging3
Islet Cell Therapy and Stem Cell Therapy for Type 1 Diabetes3
New and Emerging Therapies for Dyslipidemia3
Management of Dyslipidemia in Endocrine Diseases3
Thyroid Dysfunction from Treatments for Solid Organ Cancers3
Type 1 Diabetes and Aging3
Intervention with Therapeutic Agents, Understanding the Path to Remission in Type 2 Diabetes3
The Interlink Between Metabolic-Associated Fatty Liver Disease and Polycystic Ovary Syndrome3
Nontraditional Aspects of Sporadic Primary Hyperparathyroidism3
Lipoprotein Assessment in the twenty-first Century3
Prevention of Diabetes Macrovascular Complications and Heart Failure3
Hyperandrogenic Anovulation3
Fertility Considerations in Hypogonadal Men3
Age-Associated Abnormalities of Water Homeostasis3
Pathobiology of Metabolic-Associated Fatty Liver Disease3
Diagnosis and Evaluation of Hypogonadism3
Metabolic-Associated Fatty Liver Disease and Diabetes3
Rare Causes of Hypercalcemia3
Ameliorating Cardiovascular Risk in Patients with Type 2 Diabetes3
Update on Approaches to Improve Delivery and Quality of Care for People with Diabetes3
Drug-Related Hypercalcemia3
Endocrine Disorders with Parathyroid Hormone-Independent Hypercalcemia3
Minimally Invasive Techniques for the Management of Thyroid Nodules3
High-Density Lipoprotein and Cardiovascular Disease—Where do We Stand?2
Sporadic Primary Hyperparathyroidism2
Testicular Dysfunction Among Cancer Survivors2
Preconception Counseling and Care for Pregnant Women with Thyroid Disease2
Anticipation of Precision Diabetes and Promise of Integrative Multi-Omics2
Updates on Osteoporosis2
Endocrinology and Metabolism Clinics of North America2
Endoscopic Treatments for Obesity2
Hormonal Injustice2
100 years of Insulin: Why is Insulin So Expensive and What Can be Done to Control Its Cost?2
LDL Cholesterol—How Low Can We Go?2
Lipid Disorders and Metabolic-Associated Fatty Liver Disease2
Male Reproduction and Aging2
Body Image Disorders and Anabolic Steroid Withdrawal Hypogonadism in Men2
Metabolic-Associated Fatty Liver Disease in Childhood and Adolescence2
The Effects of Testosterone Treatment on Cardiovascular Health2
A Bidirectional Association Between Obstructive Sleep Apnea and Metabolic-Associated Fatty Liver Disease2
Intervention with Therapeutic Agents, Understanding the Path to Remission to Type 2 Diabetes1
Recognizing and Addressing Health Inequities in Endocrinology and Diabetes1
Lean Metabolic-Associated Fatty Liver Disease1
Big Fish or No Fish; Eicosapentaenoic Acid and Cardiovascular Disease1
Racial and Ethnic Disparities in Access to and Outcomes of Infertility Treatment and Assisted Reproductive Technology in the United States1
Interventions Across the Translational Research Spectrum1
Use of Testosterone in Postmenopausal Women1
Obesity1
Physiology Reconfigured: How Does Bariatric Surgery Lead to Diabetes Remission?1
Acute and Chronic Adverse Outcomes of Type 1 Diabetes1
Evaluation and Management of Lipids and Lipoproteins in Children and Adolescents1
Population-Level Approaches to Preventing Type 2 Diabetes Globally1
Emerging and Public Health Challenges Existing in Gestational Diabetes Mellitus and Diabetes in Pregnancy1
Iatrogenic Obesity1
Evaluating Patient-Reported Outcomes in Cushing’s Syndrome1
Testosterone Treatment and the Risk of Prostate Adverse Events1
The Benefits and Risks of Testosterone Treatment in Older Hypogonadal Men1
Remission with an Intervention1
Updates on Osteoporosis1
Metabolic-Associated Fatty Liver Disease and the Gut Microbiota1
Pituitary Endocrinology in 2020: An Update1
Thyroid Disorders: An Update1
Risks of Testosterone for Postmenopausal Women1
Management of Metabolic-Associated Fatty Liver Disease1
Sex Hormones and Cardiovascular Disease in Relation to Menopause1
Emerging Technologies and Therapeutics for Type 1 Diabetes1
Less-Intensive Management Options for Low-Risk Thyroid Cancer1
Use of Patient-Reported Outcomes for Assessing Diabetes Outcomes1
Newer Glucose-Lowering Therapies in Older Adults with Type 2 Diabetes1
Novel Therapeutics for Advanced Differentiated Thyroid Cancer1
Metabolic-Associated Fatty Liver Disease: A Disastrous Human Health Challenge1
Optimized Use of the Electronic Health Record and Other Clinical Resources to Enhance the Management of Hypogonadal Men1
Insights into the Genetic Underpinnings of Endocrine Traits from Large-Scale Genome-Wide Association Studies1
Quality of Life in Patients with Adrenal Insufficiency1
Equity in Obesity Review1
Monitoring of Testosterone Replacement Therapy to Optimize the Benefit-to-Risk Ratio1
Patient-Reported Outcomes in Endoscopic Endonasal Skull Base Surgery1
2021 Updates on Osteoporosis Diagnosis and Therapy1
Advances in Pharmacotherapeutics, Metabolic Surgery, and Technology for Diabetes1
Type 1 Diabetes and Cardiovascular Health1
Growth Hormone and Aging1
Pregnancy and Metabolic-Associated Fatty Liver Disease1
0.019829034805298